---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-161587"
form_type: "8-K"
ticker: "IRON"
cik: "0001816736"
company_name: "Disc Medicine, Inc."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:23:53.530744+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Disc Medicine prices $178M underwritten offering of 4.94M shares at $36.00

## Summary
- Priced 4,944,000 shares at $36.00; gross proceeds ~$178M, net ~$172.3M.
- Offering led by Frazier Life Sciences and Logos Capital with other institutional investors.
- Net proceeds to fund clinical development, R&D, and working capital; cash runway extended into 2027.
- Expected to close June 17, 2024; Leerink Partners acts as sole bookrunner.
- Offered under effective shelf registration statement (Form S-3, No. 333-275652).

## SEC filing metadata
- accession: 0001193125-24-161587
- form_type: 8-K
- ticker: IRON
- cik: 0001816736
- company_name: Disc Medicine, Inc.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816736/000119312524161587/0001193125-24-161587-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816736/000119312524161587/d828009d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-161587
- JSON: https://secwatch.observer/filing/0001193125-24-161587.json
- Plain text: https://secwatch.observer/filing/0001193125-24-161587.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.